HCA Healthcare, Inc. (NYSE:HCA) Announces $0.78 Quarterly Dividend

HCA Healthcare, Inc. (NYSE:HCA) announced a quarterly dividend on Thursday, July 23rd. Stockholders of record on Wednesday, September 16th will be given a dividend of 0.78 per share on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th.

HCA Healthcare has raised its dividend payment by an average of 0.3%per year over the last three years and has raised its dividend every year for the last 6 years. HCA Healthcare has a payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect HCA Healthcare to earn $32.05 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.7%.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $427.51 on Monday. The stock has a market cap of $92.56 billion, a price-to-earnings ratio of 14.31, a PEG ratio of 1.40 and a beta of 1.10. The business has a 50 day simple moving average of $404.99 and a 200 day simple moving average of $432.69. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the company posted $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, analysts predict that HCA Healthcare will post 29.42 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on HCA. Barclays cut their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a report on Tuesday, September 8th. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a research report on Tuesday, July 14th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research report on Tuesday, July 7th. Finally, Truist Financial dropped their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.